Riemer R K, Goldfien A C, Goldfien A, Roberts J M
Endocrinology. 1986 Aug;119(2):699-709. doi: 10.1210/endo-119-2-699.
We examined the relation between increased uterine oxytocin receptor concentration and increased in vivo sensitivity of the rabbit uterus to oxytocin at the end of gestation. We determined oxytocin receptor concentrations in myometrium and decidua on different days near term of gestation and postpartum. We also examined the in vitro contractile response to oxytocin on days 30 and 5 days postpartum, when the uterus is unresponsive in vivo, and on day 31 (term), when the uterus is exquisitely sensitive to this hormone in vivo. In addition, we tested the role of endogenous eicosanoids and decidual oxytocin receptors in the myometrial contractile response to oxytocin by examining the contractile response in the presence of the cyclooxygenase/lipoxygenase inhibitor sodium meclofenamate or in muscle strips from which the decidua had been removed by scraping. The concentration of specific binding sites for [3H]oxytocin in myometrial and also decidual membrane preparations was determined. We demonstrate that contractile sensitivity to oxytocin increases at least 4-fold between days 30 and 31 (term) of gestation, and this is accompanied by a nearly 10-fold increase in the concentration of oxytocin-binding sites in both decidua and myometrium. The lesser sensitivity to oxytocin on day 30 was, however, only apparent in the presence of meclofenamate, which suggests that endogenous eicosanoids contribute to the preterm response to oxytocin measured in vitro. The maximal response to oxytocin (integrated area) increased 2-fold between day 30 and term. Thus, an increase in both sensitivity and maximal response to oxytocin could be demonstrated at term in vitro. Five days after parturition, maximal response and uterine sensitivity measured in the presence of meclofenamate had returned to those of the preterm uterus, and the concentration of oxytocin-binding sites had declined. In contrast, sensitivity and maximal response to the cholinergic agonist carbamylcholine declined between day 30 and term. These results support a highly regulated physiological role for oxytocin in parturition which depends primarily on changes in receptor concentration.
我们研究了妊娠末期兔子宫中催产素受体浓度增加与子宫对催产素体内敏感性增加之间的关系。我们测定了妊娠晚期和产后不同时间点子宫肌层和蜕膜中催产素受体的浓度。我们还检测了产后第30天和第5天(此时子宫在体内无反应)以及第31天(足月时)子宫对催产素的体外收缩反应,足月时子宫在体内对这种激素极为敏感。此外,我们通过在环氧化酶/脂氧合酶抑制剂甲氯芬那酸钠存在的情况下检测收缩反应,或通过刮除蜕膜的肌条来检测内源性类花生酸和蜕膜催产素受体在子宫肌层对催产素收缩反应中的作用。测定了子宫肌层和蜕膜制剂中[3H]催产素特异性结合位点的浓度。我们证明,在妊娠第30天至第31天(足月时)之间,子宫对催产素的收缩敏感性至少增加了4倍,同时蜕膜和子宫肌层中催产素结合位点的浓度增加了近10倍。然而,第30天对催产素较低的敏感性仅在甲氯芬那酸钠存在的情况下才明显,这表明内源性类花生酸有助于体外测量的早产时对催产素的反应。从第30天到足月,对催产素的最大反应(积分面积)增加了2倍。因此,在足月时体外可证明对催产素的敏感性和最大反应均增加。分娩后5天,在甲氯芬那酸钠存在的情况下测量的最大反应和子宫敏感性已恢复到早产子宫的水平,催产素结合位点的浓度下降。相反,从第30天到足月,对胆碱能激动剂氨甲酰胆碱的敏感性和最大反应下降。这些结果支持了催产素在分娩中具有高度调节的生理作用,这主要取决于受体浓度的变化。